PF

PSIM fund

Description

PSIM fund

Investor Profile

PSIM fund has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Post Ipo Equity (33%)

Country Focus

  • France (100%)

Industry Focus

  • Biomass Energy
  • Innovation Management
  • Manufacturing
  • Renewable Energy
  • Health Diagnostics
  • Medical
  • Oncology
  • Pharmaceutical
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PSIM fund frequently co-invest with?

Air Liquide ALIAD
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Co-Investments: 1
Normandie Participations
Europe, Basse-Normandie, France, Colombelles
Co-Investments: 1
AP Ventures
Europe, Enfield, United Kingdom, Enfield
Co-Investments: 1
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Kouros
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
QF
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Sham
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1
AC
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Demeter
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by PSIM fund?

MaaT Pharma

Lyon, Rhone-Alpes, France

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

BiotechnologyHealth Care
Post Ipo EquityMar 27, 2025
Amount Raised: $14,041,060
Ergosup

Malataverne, Rhone-Alpes, France

Ergosup developes an innovative process for producing high pressure hydrogen on site for refueling hydrogen fuel vehicles.

Biomass EnergyInnovation ManagementManufacturingRenewable Energy
Series BFeb 18, 2019
Amount Raised: $12,442,820
HalioDx

Marseille, Provence-Alpes-Cote d'Azur, France

HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.

Health DiagnosticsMedicalOncologyPharmaceutical
Series BJan 17, 2018
Amount Raised: $22,533,825